Ocrelizumab for Post-Alemtuzumab Paradoxical Disease Activity in Highly Active Multiple Sclerosis

We present a case of a person with multiple sclerosis with severe disease activation after alemtuzumab administration that may represent paradoxical B cell–mediated disease activity. The patient was successfully treated with ocrelizumab.
Source: Clinical Neuropharmacology - Category: Neurology Tags: Case Reports Source Type: research